Optimized mixture of hops rho iso-alpha acids-rich extract and acacia proanthocyanidins-rich extract reduces insulin resistance in 3T3-L1 adipocytes and improves glucose and insulin control in db/db mice

Rho iso-alpha acids-rich extract (RIAA) from Humulus lupulus (hops) and proanthocyanidins-rich extracts (PAC) from Acacia nilotica exert anti-inflammatory and anti-diabetic activity in vitro and in vivo. We hypothesized that a combination of these two extracts would exert enhanced effects in vitro o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutrition research and practice 2012, 6(5), , pp.405-413
Hauptverfasser: Tripp, Matthew L., MetaProteomics LLC, Gig Harbor, WA, USA, Darland, Gary, MetaProteomics LLC, Gig Harbor, WA, USA, Konda, Veera Reddy, MetaProteomics LLC, Gig Harbor, WA, USA, Pacioretty, Linda M., Bionexus, Ltd., Ithaca, NY, USA, Chang, J.L., MetaProteomics LLC, Gig Harbor, WA, USA, Bland, Jeffrey S., MetaProteomics LLC, Gig Harbor, WA, USA, Babish, John G., Bionexus, Ltd., Ithaca, NY, USA
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Rho iso-alpha acids-rich extract (RIAA) from Humulus lupulus (hops) and proanthocyanidins-rich extracts (PAC) from Acacia nilotica exert anti-inflammatory and anti-diabetic activity in vitro and in vivo. We hypothesized that a combination of these two extracts would exert enhanced effects in vitro on inflammatory markers and insulin signaling, and on nonfasting glucose and insulin in db/db mice. Over 49 tested combinations, RIAA:PAC at 5:1(6.25 ㎍/mL) exhibited the greatest reductions in TNFα-stimulated lipolysis and IL-6 release in 3T3-L1 adipocytes, comparable to 5 ㎍/mL troglitazone. Pretreatment of 3T3-L1 adipocytes with this combination (5 ㎍/mL) also led to a 3-fold increase in insulin-stimulated glucose uptake that was comparable to 5 ㎍/mL pioglitazone or 901 mu g/mL aspirin. Finally, db/db mice fed with RIAA:PAC at 5:1(100 mg/kg) for 7 days resulted in 22% decrease in nonfasting glucose and 19% decrease in insulin that was comparable to 0.5 mg/kg rosiglitazone and better than 100 mg/kg metformin. RIAA:PAC mixture may have the potential to be an alternative when conventional therapy is undesirable or ineffective, and future research exploring its long-term clinical application is warranted.
ISSN:1976-1457
2005-6168
DOI:10.4162/nrp.2012.6.5.405